Sanofi completed a $180m investment in Owkin.

Sanofi, an innovative therapeutic solutions provider, completed a $180m investment in Owkin, a machine learning provider. "Owkin’s unique methodology, which applies AI on patient data from partnerships with multiple academic medical centers, supports our ambition to leverage data in innovative ways in R&D. We are striving to advance precision medicine to the next level and to discover innovative treatment methods with the greatest benefits for patients," Arnaud Robert, Sanofi Executive Vice Presidenta and Chief Digital Officer.